The osteoclast: A multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell

被引:223
作者
Bar-Shavit, Zvi [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Hubert H Humphrey Ctr Expt Med & Canc Res, IL-91120 Jerusalem, Israel
关键词
osteoclast; bone-resorption; osteoimmunology; cell differentiation; cell fusion;
D O I
10.1002/jcb.21553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoclasts are multinucleated cells that derive from hematopoietic progenitors in the bone marrow which also give rise to rnonocytes in peripheral blood, and to the various types Of tissue macrophages. Osteoclasts are formed by the fusion of precursor cells. They function in bone resorption and are therefore critical for normal skeletal development (growth and modeling), for the maintenance of its integrity throughout life, and for calcium metabolism (remodeling). To resorb bone, the osteoclasts attach to the bone matrix, their cytoskeleton reorganizes, and they assume polarized morphology and form ruffled borders to secrete acid and collagenolytic enzymes and a sealing zone to isolate the resorption site. Identification of the osteoclastogenesis inducer, the receptor activator of nuclear factor-kappa B ligand (RANKL), its cognate receptor RANK, and its decoy receptor osteoprotegerin (OPG), has contributed enormously to the dramatic advance in our understanding of the molecular mechanisms involved in osteoclast differentiation and activity. This explosion in osteoclast biology is reflected by the large number of reviews which appeared during the last decade. Here I will summarize the "classical" issues (origin, differentiation, and activity) in a general manner, and will discuss an untouched issue (multinucleation) and a relatively novel aspect of osteoclast biology (osteoimmunology).
引用
收藏
页码:1130 / 1139
页数:10
相关论文
共 54 条
[41]   Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 [J].
Tondravi, MM ;
McKercher, SR ;
Anderson, K ;
Erdmann, JM ;
Quiroz, M ;
Maki, R ;
Teitelbaum, SL .
NATURE, 1997, 386 (6620) :81-84
[42]   Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases [J].
Trebec, Diana P. ;
Chandra, Divya ;
Gramoun, Azza ;
Li, Keying ;
Heersche, Johan N. M. ;
Manolson, Morris F. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (01) :205-220
[43]   Mechanism of osteoclast mediated bone resorption -: rationale for the design of new therapeutics [J].
Väänänen, K .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (07) :959-971
[44]   BONE-RESORPTION RESTORED IN OSTEOPETROTIC MICE BY TRANSPLANTS OF NORMAL BONE-MARROW AND SPLEEN-CELLS [J].
WALKER, DG .
SCIENCE, 1975, 190 (4216) :784-785
[45]   Osteoimmunology: Interplay between the immune system and bone metabolism [J].
Walsh, Matthew C. ;
Kim, Nacksung ;
Kadono, Yuho ;
Rho, Jaerang ;
Lee, Soo Young ;
Lorenzo, Joseph ;
Choi, Yongwon .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :33-63
[46]  
WEINSTEIN RS, 1995, P 2 INT S PAG DIS BO
[47]   The role of T lymphocytes in bone metabolism [J].
Weitzmann, MN ;
Pacifici, R .
IMMUNOLOGICAL REVIEWS, 2005, 208 :154-168
[48]   Recognition and signaling by toll-like receptors [J].
West, A. Phillip ;
Koblansky, Anna Alicia ;
Ghosh, Sankar .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2006, 22 :409-437
[49]   TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology [J].
Wu, H ;
Arron, JR .
BIOESSAYS, 2003, 25 (11) :1096-1105
[50]   DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells [J].
Yagi, M ;
Miyamoto, T ;
Sawatani, Y ;
Iwamoto, K ;
Hosogane, N ;
Fujita, N ;
Morita, K ;
Ninomiya, K ;
Suzuki, T ;
Miyamoto, K ;
Oike, Y ;
Takeya, M ;
Toyama, Y ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (03) :345-351